Literature DB >> 7531953

New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.

D J Reynolds1, P M Banks, M L Gulley.   

Abstract

Recent nucleic acid hybridization studies have implied that Reed-Sternberg/Hodgkin (RS/H) cells are infected with Epstein-Barr virus (EBV) before malignant transformation, and hence, that Hodgkin's disease could develop as a consequence of malignant transformation of an EBV-infected cell. This study is a detailed immunohistochemical and in situ hybridization characterization of the various lymphoid cells in nine cases of infectious mononucleosis (IM), the acute manifestation of EBV infection. The RS/H-like cells of IM were similar in most respects to their morphologically identical counterparts in Hodgkin's disease; they expressed the EBV-encoded protein LMP1, EBV EBER1 transcripts, and CD30 and rarely, if ever, expressed CD45/LCA or T cell markers. Dissimilarities were limited to CD15 negativity and the absence of a collarette of T cells around the RS/H-like cells of IM compared with their Hodgkin's counterparts. Expression of the immortalizing bcl-2 oncoprotein was variable in the RS/H-like cells of IM, as has been demonstrated in the RS/H cells of Hodgkin's disease by other investigators. An apoptosis assay suggested that many apoptotic cells in IM were EBV-infected T cells, in keeping with the previous in vitro observation that IM-derived T cells succumb to apoptosis. Additionally, the apoptosis assay suggested that RS/H-like cells of IM can succumb to programmed cell death, reminiscent of the mummified RS/H cells seen in Hodgkin's disease. The accumulation of evidence suggests that RS/H-like cells of IM are more similar to true RS/H cells than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531953      PMCID: PMC1869866     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.

Authors:  S M Chittal; P Caverivière; R Schwarting; J Gerdes; T Al Saati; F Rigal-Huguet; H Stein; G Delsol
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

2.  Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods.

Authors:  J M Elias; M Margiotta; D Gaborc
Journal:  Am J Clin Pathol       Date:  1989-07       Impact factor: 2.493

3.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  L M Weiss; L A Movahed; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

4.  The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.

Authors:  S Poppema
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

5.  Monoclonal antibodies Ki-B3 and Leu-M1 discriminate giant cells of infectious mononucleosis and of Hodgkin's disease.

Authors:  C Fellbaum; M L Hansmann; M R Parwaresch; K Lennert
Journal:  Hum Pathol       Date:  1988-10       Impact factor: 3.466

6.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.

Authors:  N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

7.  Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

Authors:  N Rosdahl; S O Larsen; J Clemmesen
Journal:  Br Med J       Date:  1974-05-04

8.  Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils.

Authors:  C C Childs; D M Parham; C W Berard
Journal:  Am J Surg Pathol       Date:  1987-02       Impact factor: 6.394

9.  Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity.

Authors:  M L Gulley; P A Eagan; L Quintanilla-Martinez; A L Picado; B N Smir; C Childs; C D Dunn; F E Craig; J W Williams; P M Banks
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

Review 10.  Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.

Authors:  N Mueller
Journal:  Yale J Biol Med       Date:  1987 Jul-Aug
View more
  7 in total

1.  Turnover of T cells in murine gammaherpesvirus 68-infected mice.

Authors:  A M Hamilton-Easton; J P Christensen; P C Doherty
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  Molecular diagnosis of Epstein-Barr virus-related diseases.

Authors:  M L Gulley
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

3.  Lymphoid tissues from patients with infectious mononucleosis lack monoclonal B and T cells.

Authors:  Julie A Plumbley; Hongxin Fan; Phyllis A Eagan; Aamir Ehsan; Bertram Schnitzer; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

4.  Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome.

Authors:  J W Brooks; A M Hamilton-Easton; J P Christensen; R D Cardin; C L Hardy; P C Doherty
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

Authors:  H Kanzler; R Küppers; M L Hansmann; K Rajewsky
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

6.  Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

Authors:  R A Tripp; A M Hamilton-Easton; R D Cardin; P Nguyen; F G Behm; D L Woodland; P C Doherty; M A Blackman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

Review 7.  The Grey Zones of Classic Hodgkin Lymphoma.

Authors:  Jan Bosch-Schips; Massimo Granai; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.